Posts

Showing posts from May, 2024

IBRX Is The Next One To Squeeze After GME

Image
Yesterday we talked about the correlation between GameStop Corp. (GME) and several other short squeeze plays, namely ImmunityBio, Inc. (IBRX). Unfortunately for IBRX longs that didn't pan out today as GME rose over 60% but IBRX dropped 2%. In the morning it was looking like IBRX was going to follow GME as it was up 5%, but unfortunately GME pulled back from its pre-market spike to $80 so the impact was short lived on many short squeeze plays, including IBRX. What people need to realize is that short squeezes are all connected. The same firms short several of the most popular shorted stocks and the same mechanisms that allow shorts to gain a position in the first place exist across all of them. If one heavily shorted stock squeezes, others will follow. When we compare the stats of GME to IBRX, they are very similar, with IBRX having a slight advantage. As the shorts capitulate on GME, look for IBRX to follow.

The Three Stocks Winning Alongside The GME Squeeze

Image
This morning GameStop Corp. (GME) has been on fire as Roaring Kitty has returned. Stocks like Koss Corporation (KOSS), BlackBerry Limited (BB) and most notably AMC Entertainment Holdings, Inc. (AMC) are up in sympathy, though they have given up a lot of their gains.  What people need to realize is that short squeezes are all connected. There are three stocks right now that are moving up as part of the GME squeeze that are under-the-radar but are certainly correlated. The first and most obvious one is ImmunityBio, Inc. (IBRX). It was quiet at first, but shortly after GME broke $30, it moved 5% to around $8.50 and sits near its day high at the time of this write up.  When we compare the stats of GME to IBRX, they are very similar, with IBRX having a slight advantage. As the shorts capitulate on GME, look for IBRX to follow. The second one is Dave Inc. (DAVE), which has a very similar 5% spike once GME broke $30: DAVE last week had strong earnings which drove the stock price up and has a

The Two Best Biotech Short Squeeze Candidates And The Next Carvana

Image
With the market having recovered most of its recent drop to be near all-time highs once again, shorts have been destroyed and are in a desperate spot. Heavily shorted stocks like B. Riley Financial, Inc. (RILY), Globe Life Inc. (GL) and Carvana Co. (CVNA) have been on absolute tears. We have written about CVNA before , as well as the impact of CVNA's move on Root , Inc. (ROOT). When a stock is squeezing like CVNA, a related stock like ROOT will follow suit. Shorts are often shorting multiple related stocks. Most don't even hide it with Kerrisdale openly bragging about its poor track record. GL was another one that was attacked by shorts which we talked about as a gamma squeeze candidate that has worked out very well over the past three weeks.  In this market of short squeezes, we have identified two excellent biotech short squeeze candidates, ImmunityBio, Inc. (IBRX) and Soleno Therapeutics, Inc. (SLNO). IBRX is starting up the production and sale of its cancer drug ANKTIVA. S